These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

303 related articles for article (PubMed ID: 37149607)

  • 1. Advanced cancer targeting using aptamer functionalized nanocarriers for site-specific cargo delivery.
    Narwade M; Shaikh A; Gajbhiye KR; Kesharwani P; Gajbhiye V
    Biomater Res; 2023 May; 27(1):42. PubMed ID: 37149607
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nucleic acid aptamer application in diagnosis and therapy of colorectal cancer based on cell-SELEX technology.
    Chen C; Zhou S; Cai Y; Tang F
    NPJ Precis Oncol; 2017; 1(1):37. PubMed ID: 29872716
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chimeric aptamers in cancer cell-targeted drug delivery.
    Kanwar JR; Roy K; Kanwar RK
    Crit Rev Biochem Mol Biol; 2011 Dec; 46(6):459-77. PubMed ID: 21955150
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Advances in Aptamer-Based Biosensors and Cell-Internalizing SELEX Technology for Diagnostic and Therapeutic Application.
    Gan Z; Roslan MAM; Abd Shukor MY; Halim M; Yasid NA; Abdullah J; Md Yasin IS; Wasoh H
    Biosensors (Basel); 2022 Oct; 12(11):. PubMed ID: 36354431
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Application and development of aptamer in cancer: from clinical diagnosis to cancer therapy.
    Han J; Gao L; Wang J; Wang J
    J Cancer; 2020; 11(23):6902-6915. PubMed ID: 33123281
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Oligonucleotide aptamers for glioma targeting: an update.
    Camorani S; Cerchia L
    Cent Nerv Syst Agents Med Chem; 2015; 15(2):126-37. PubMed ID: 25924917
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Efficient screening for 8-oxoguanine DNA glycosylase binding aptamers via capillary electrophoresis].
    Han S; Zhao L; Yang G; Qu F
    Se Pu; 2021 Jul; 39(7):721-729. PubMed ID: 34227370
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Breaking Barriers: Nucleic Acid Aptamers in Gastrointestinal (GI) Cancers Therapy.
    Uinarni H; Oghenemaro EF; Menon SV; Hjazi A; Ibrahim FM; Kaur M; Zafarjonovna AZ; Deorari M; Jabir MS; Zwamel AH
    Cell Biochem Biophys; 2024 Jun; ():. PubMed ID: 38916791
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Advancements in complex target systematic evolution of ligands by exponential enrichment].
    Wu Z; Xue S; Yang Y
    Se Pu; 2018 Oct; 36(10):947-951. PubMed ID: 30378352
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Structural optimization of an aptamer generated from Ligand-Guided Selection (LIGS) resulted in high affinity variant toward mIgM expressed on Burkitt's lymphoma cell lines.
    Zümrüt HE; Batool S; Van N; George S; Bhandari S; Mallikaratchy P
    Biochim Biophys Acta Gen Subj; 2017 Jul; 1861(7):1825-1832. PubMed ID: 28363693
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Selection of DNA Aptamers Recognizing EpCAM-Positive Prostate Cancer by Cell-SELEX for in vitro and in vivo MR Imaging.
    Zhong J; Ding J; Deng L; Xiang Y; Liu D; Zhang Y; Chen X; Yang Q
    Drug Des Devel Ther; 2021; 15():3985-3996. PubMed ID: 34584404
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Selection of Nucleic Acid Aptamers Targeting Tumor Cell-Surface Protein Biomarkers.
    Mercier MC; Dontenwill M; Choulier L
    Cancers (Basel); 2017 Jun; 9(6):. PubMed ID: 28635657
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Capture-SELEX: Selection Strategy, Aptamer Identification, and Biosensing Application.
    Lam SY; Lau HL; Kwok CK
    Biosensors (Basel); 2022 Dec; 12(12):. PubMed ID: 36551109
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Aptamers and Their Significant Role in Cancer Therapy and Diagnosis.
    Prakash JS; Rajamanickam K
    Biomedicines; 2015 Sep; 3(3):248-269. PubMed ID: 28536411
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Aptamer nucleotide analog drug conjugates in the targeting therapy of cancers.
    Li Y; Zhao J; Xue Z; Tsang C; Qiao X; Dong L; Li H; Yang Y; Yu B; Gao Y
    Front Cell Dev Biol; 2022; 10():1053984. PubMed ID: 36544906
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cancer immunotherapy via nucleic acid aptamers.
    Khedri M; Rafatpanah H; Abnous K; Ramezani P; Ramezani M
    Int Immunopharmacol; 2015 Dec; 29(2):926-936. PubMed ID: 26603636
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nucleic Acid aptamers: new methods for selection, stabilization, and application in biomedical science.
    Kong HY; Byun J
    Biomol Ther (Seoul); 2013 Nov; 21(6):423-34. PubMed ID: 24404332
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Improving aptamer performance with nucleic acid mimics: de novo and post-SELEX approaches.
    Oliveira R; Pinho E; Sousa AL; DeStefano JJ; Azevedo NF; Almeida C
    Trends Biotechnol; 2022 May; 40(5):549-563. PubMed ID: 34756455
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The application of aptamers in cancer research: an up-to-date review.
    Hu M; Zhang K
    Future Oncol; 2013 Mar; 9(3):369-76. PubMed ID: 23469972
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification and Engineering of Aptamers for Theranostic Application in Human Health and Disorders.
    Basu D; Chakraborty S; Pal R; Sharma TK; Sarkar S
    Int J Mol Sci; 2021 Sep; 22(18):. PubMed ID: 34575825
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.